PDS Biotechnology Corporation (PDSB) Business News Dec. 02, 2025, 13:30 UTC PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration (“FDA”) Full text
Register to leave comments News bot Dec. 2, 2025, 1:40 p.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical